Please use the following link to go directly to the EUROmediCAT website http://euromedicat.eu/
We have also been successful in attracting FP7 funding to develop EUROmediCAT, a daughter of EUROCAT. EUROmediCAT will enhance exposure data by linkage of registries to prescription data, and will specifically concentrate on new anti-epileptics, insulin analogues, anti-asthmatics and anti-depressants. The project will run from March 1, 2011 till February, 28 2015. For more information on this FP7 funded project, see the EUROmediCAT website, which will be active soon. [http://www.euromedicat.eu/]
In EUROmediCAT we aim to build a European system for reproductive safety evaluation
- to identify systematically and comprehensively the possible adverse effects in pregnancy of a drug at the earliest stage post marketing
- and to monitor and evaluate safety measures undertaken inEurope.
EUROmediCAT is a project funded under the European Union's 7th FrameworkProgramme.